Christopher Hunt Keir
- Oncology top 5%
- Molecular Biology
- Biomedical Engineering
- Genetics top 10%
- Immunology
- Co-authors
- James MiskinBruce L. LevineKeith WonnacottLinda T. VahdatEric Q. WuAnnie GuérinJie ZhangAlessandro Crotta
- Topics
- Chronic Myeloid Leukemia Treatments (7 papers)Gastrointestinal Tumor Research and Treatment (7 papers)Gastric Cancer Management and Outcomes (7 papers)
- Cited by
- OncologyHematologyGenetics
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Christopher Hunt Keir
25 papers receiving 847 citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 613
- Molecular Biology 326
- Biomedical Engineering 211
- Genetics 189
- Immunology 137
Countries citing papers authored by Christopher Hunt Keir
This map shows the geographic impact of Christopher Hunt Keir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Hunt Keir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Hunt Keir more than expected).
Fields of papers citing papers by Christopher Hunt Keir
This network shows the impact of papers produced by Christopher Hunt Keir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Hunt Keir. The network helps show where Christopher Hunt Keir may publish in the future.
Co-authorship network of co-authors of Christopher Hunt Keir
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Hunt Keir. A scholar is included among the top collaborators of Christopher Hunt Keir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Hunt Keir. Christopher Hunt Keir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 17 | |
| 3 | Global Manufacturing of CAR T Cell Therapybreakdown → | 537 |
| 4 | 53 | |
| 5 | 2 | |
| 6 | 23 | |
| 7 | 27 | |
| 8 | 6 | |
| 9 | 14 | |
| 10 | 2 | |
| 11 | 5 | |
| 12 | 48 | |
| 13 | 11 | |
| 14 | 1 | |
| 15 | 1 | |
| 16 | 1 | |
| 17 | 2 | |
| 18 | 2 | |
| 19 | 27 | |
| 20 | 19 |
About Christopher Hunt Keir
Christopher Hunt Keir is a scholar working on Gastroenterology, Hematology and Genetics, having authored 25 papers that have together received 867 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (7 papers), Gastrointestinal Tumor Research and Treatment (7 papers) and Gastric Cancer Management and Outcomes (7 papers). The work is most often cited by research in Oncology (613 citations), Hematology (115 citations) and Genetics (80 citations). Christopher Hunt Keir has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include James Miskin, Bruce L. Levine, Keith Wonnacott, Linda T. Vahdat, Eric Q. Wu, Annie Guérin, Jie Zhang, Alessandro Crotta, Edmund K. Waller and Gary Douglas Myers. Their work appears in journals such as Journal of Clinical Oncology, Blood and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.